[Federal Register Volume 84, Number 101 (Friday, May 24, 2019)]
[Notices]
[Pages 24166-24167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10944]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be held as a teleconference only and is open to
the public to dial-in for participation. Individuals who plan to dial-
in to the meeting and need special assistance or other reasonable
accommodations in order to do so, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee; Translational Research
Strategy Subcommittee (TRSS).
Date: June 19, 2019,
Time: 10:00 a.m. to 11:00 a.m.
Agenda: Review the Glioblastoma (GBM) Working Group Report.
Place: National Cancer Institute Shady Grove, Shady Grove, 9609
Medical Center Drive, Rockville, MD 20850 (Telephone Conference
Call), Phone: 240-276-6500, Conference Code: 1102766460, Passcode:
6460.
Contact Person: Peter Ujhazy, MD, Ph.D., Deputy Associate
Director, Translational Research Program, Division of Cancer
Treatment and Diagnosis, National Institutes of Health, National
Cancer Institute, 9609 Medical Center Drive, Room 3W106, Rockville,
MD 20850, 240-276-5681, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on
[[Page 24167]]
this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 21, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-10944 Filed 5-23-19; 8:45 am]
BILLING CODE 4140-01-P